COMPUESTOS HETEROCICLICOS NOVEDOSOS Y USOS DE LOS MISMOS
COMPUESTOS HETEROCÍCLICOS SUSTITUIDOS, COMPOSICIONES QUE LOS CONTIENEN, Y MÉTODOS PARA UTILIZARLOS PARA LA INHIBICIÓN DE ACTIVIDAD DE LA CINASA RAF. LOS NUEVOS COMPUESTOS Y COMPOSICIONES SE PUEDEN UTILIZAR YA SEA SOLOS O BIEN EN COMBINACION CON CUANDO MENOS UN AGENTE ADICIONAL PARA EL TRATAMIENTO DE...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MACHAJEWSKI TIMOTHY D MCKENNA MAUREEN ZHANG QIONG SENDZIK MARTIN POON DANIEL ANTONIOS-MCCREA WILLIAM R HUANG ZILIN JIN JEFF XU YONGJIN SHAFER CYNTHIA M RENHOWE PAUL A SMITH AARON |
| description | COMPUESTOS HETEROCÍCLICOS SUSTITUIDOS, COMPOSICIONES QUE LOS CONTIENEN, Y MÉTODOS PARA UTILIZARLOS PARA LA INHIBICIÓN DE ACTIVIDAD DE LA CINASA RAF. LOS NUEVOS COMPUESTOS Y COMPOSICIONES SE PUEDEN UTILIZAR YA SEA SOLOS O BIEN EN COMBINACION CON CUANDO MENOS UN AGENTE ADICIONAL PARA EL TRATAMIENTO DE UN TRASTORNO MEDIADO POR LA CINASA RAF, TAL COMO CÁNCER
Novel imidazole compounds of the general formula are disclosed, wherein R1 and R2 comprise heteroaryl groups. These compounds and compositions containing them are useful in methods to treat Raf kinase-mediated disorders such as cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SV2010003673A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SV2010003673A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SV2010003673A3</originalsourceid><addsrcrecordid>eNrjZLBw9vcNCHUNDvEPVvBwDXEN8nf2dPbxdAZy_fzDXF38g4GsSIVQEOXiquADpHw9g339g3kYWNMSc4pTeaE0N4OSm2uIs4duakF-fGpxQWJyal5qSXxwmJGBoYGBgbGZubGjMVGKAOcXKVE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPUESTOS HETEROCICLICOS NOVEDOSOS Y USOS DE LOS MISMOS</title><source>esp@cenet</source><creator>MACHAJEWSKI TIMOTHY D ; MCKENNA MAUREEN ; ZHANG QIONG ; SENDZIK MARTIN ; POON DANIEL ; ANTONIOS-MCCREA WILLIAM R ; HUANG ZILIN ; JIN JEFF ; XU YONGJIN ; SHAFER CYNTHIA M ; RENHOWE PAUL A ; SMITH AARON</creator><creatorcontrib>MACHAJEWSKI TIMOTHY D ; MCKENNA MAUREEN ; ZHANG QIONG ; SENDZIK MARTIN ; POON DANIEL ; ANTONIOS-MCCREA WILLIAM R ; HUANG ZILIN ; JIN JEFF ; XU YONGJIN ; SHAFER CYNTHIA M ; RENHOWE PAUL A ; SMITH AARON</creatorcontrib><description>COMPUESTOS HETEROCÍCLICOS SUSTITUIDOS, COMPOSICIONES QUE LOS CONTIENEN, Y MÉTODOS PARA UTILIZARLOS PARA LA INHIBICIÓN DE ACTIVIDAD DE LA CINASA RAF. LOS NUEVOS COMPUESTOS Y COMPOSICIONES SE PUEDEN UTILIZAR YA SEA SOLOS O BIEN EN COMBINACION CON CUANDO MENOS UN AGENTE ADICIONAL PARA EL TRATAMIENTO DE UN TRASTORNO MEDIADO POR LA CINASA RAF, TAL COMO CÁNCER
Novel imidazole compounds of the general formula are disclosed, wherein R1 and R2 comprise heteroaryl groups. These compounds and compositions containing them are useful in methods to treat Raf kinase-mediated disorders such as cancer.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110705&DB=EPODOC&CC=SV&NR=2010003673A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110705&DB=EPODOC&CC=SV&NR=2010003673A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MACHAJEWSKI TIMOTHY D</creatorcontrib><creatorcontrib>MCKENNA MAUREEN</creatorcontrib><creatorcontrib>ZHANG QIONG</creatorcontrib><creatorcontrib>SENDZIK MARTIN</creatorcontrib><creatorcontrib>POON DANIEL</creatorcontrib><creatorcontrib>ANTONIOS-MCCREA WILLIAM R</creatorcontrib><creatorcontrib>HUANG ZILIN</creatorcontrib><creatorcontrib>JIN JEFF</creatorcontrib><creatorcontrib>XU YONGJIN</creatorcontrib><creatorcontrib>SHAFER CYNTHIA M</creatorcontrib><creatorcontrib>RENHOWE PAUL A</creatorcontrib><creatorcontrib>SMITH AARON</creatorcontrib><title>COMPUESTOS HETEROCICLICOS NOVEDOSOS Y USOS DE LOS MISMOS</title><description>COMPUESTOS HETEROCÍCLICOS SUSTITUIDOS, COMPOSICIONES QUE LOS CONTIENEN, Y MÉTODOS PARA UTILIZARLOS PARA LA INHIBICIÓN DE ACTIVIDAD DE LA CINASA RAF. LOS NUEVOS COMPUESTOS Y COMPOSICIONES SE PUEDEN UTILIZAR YA SEA SOLOS O BIEN EN COMBINACION CON CUANDO MENOS UN AGENTE ADICIONAL PARA EL TRATAMIENTO DE UN TRASTORNO MEDIADO POR LA CINASA RAF, TAL COMO CÁNCER
Novel imidazole compounds of the general formula are disclosed, wherein R1 and R2 comprise heteroaryl groups. These compounds and compositions containing them are useful in methods to treat Raf kinase-mediated disorders such as cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBw9vcNCHUNDvEPVvBwDXEN8nf2dPbxdAZy_fzDXF38g4GsSIVQEOXiquADpHw9g339g3kYWNMSc4pTeaE0N4OSm2uIs4duakF-fGpxQWJyal5qSXxwmJGBoYGBgbGZubGjMVGKAOcXKVE</recordid><startdate>20110705</startdate><enddate>20110705</enddate><creator>MACHAJEWSKI TIMOTHY D</creator><creator>MCKENNA MAUREEN</creator><creator>ZHANG QIONG</creator><creator>SENDZIK MARTIN</creator><creator>POON DANIEL</creator><creator>ANTONIOS-MCCREA WILLIAM R</creator><creator>HUANG ZILIN</creator><creator>JIN JEFF</creator><creator>XU YONGJIN</creator><creator>SHAFER CYNTHIA M</creator><creator>RENHOWE PAUL A</creator><creator>SMITH AARON</creator><scope>EVB</scope></search><sort><creationdate>20110705</creationdate><title>COMPUESTOS HETEROCICLICOS NOVEDOSOS Y USOS DE LOS MISMOS</title><author>MACHAJEWSKI TIMOTHY D ; MCKENNA MAUREEN ; ZHANG QIONG ; SENDZIK MARTIN ; POON DANIEL ; ANTONIOS-MCCREA WILLIAM R ; HUANG ZILIN ; JIN JEFF ; XU YONGJIN ; SHAFER CYNTHIA M ; RENHOWE PAUL A ; SMITH AARON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SV2010003673A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MACHAJEWSKI TIMOTHY D</creatorcontrib><creatorcontrib>MCKENNA MAUREEN</creatorcontrib><creatorcontrib>ZHANG QIONG</creatorcontrib><creatorcontrib>SENDZIK MARTIN</creatorcontrib><creatorcontrib>POON DANIEL</creatorcontrib><creatorcontrib>ANTONIOS-MCCREA WILLIAM R</creatorcontrib><creatorcontrib>HUANG ZILIN</creatorcontrib><creatorcontrib>JIN JEFF</creatorcontrib><creatorcontrib>XU YONGJIN</creatorcontrib><creatorcontrib>SHAFER CYNTHIA M</creatorcontrib><creatorcontrib>RENHOWE PAUL A</creatorcontrib><creatorcontrib>SMITH AARON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MACHAJEWSKI TIMOTHY D</au><au>MCKENNA MAUREEN</au><au>ZHANG QIONG</au><au>SENDZIK MARTIN</au><au>POON DANIEL</au><au>ANTONIOS-MCCREA WILLIAM R</au><au>HUANG ZILIN</au><au>JIN JEFF</au><au>XU YONGJIN</au><au>SHAFER CYNTHIA M</au><au>RENHOWE PAUL A</au><au>SMITH AARON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPUESTOS HETEROCICLICOS NOVEDOSOS Y USOS DE LOS MISMOS</title><date>2011-07-05</date><risdate>2011</risdate><abstract>COMPUESTOS HETEROCÍCLICOS SUSTITUIDOS, COMPOSICIONES QUE LOS CONTIENEN, Y MÉTODOS PARA UTILIZARLOS PARA LA INHIBICIÓN DE ACTIVIDAD DE LA CINASA RAF. LOS NUEVOS COMPUESTOS Y COMPOSICIONES SE PUEDEN UTILIZAR YA SEA SOLOS O BIEN EN COMBINACION CON CUANDO MENOS UN AGENTE ADICIONAL PARA EL TRATAMIENTO DE UN TRASTORNO MEDIADO POR LA CINASA RAF, TAL COMO CÁNCER
Novel imidazole compounds of the general formula are disclosed, wherein R1 and R2 comprise heteroaryl groups. These compounds and compositions containing them are useful in methods to treat Raf kinase-mediated disorders such as cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_SV2010003673A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPUESTOS HETEROCICLICOS NOVEDOSOS Y USOS DE LOS MISMOS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T08%3A29%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MACHAJEWSKI%20TIMOTHY%20D&rft.date=2011-07-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESV2010003673A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |